The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India

International Journal of Infectious Diseases

Volumn 12, Issue 5, 2008, Pages 513-518

  Saravanan, Shanmugam ^a,b   Velu, Vijayakumar ^a   Kumarasamy, Nagalingeswaran ^b   Shankar, Esaki Muthu ^b   Nandakumar, Subhadra ^a   Murugavel, Kailapuri G ^b   Balakrishnan, Pachamuthu ^b   Solomon, Sunil Suhas ^b   Solomon, Suniti ^b   Thyagarajan, Sadras Panchatcharam ^a,b,c  

^a Dr ALM Postgraduate Institute of Basic Medical Sciences   (India)

^b YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^c SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Chronic liver disease; Genotype 1b; Hepatitis B virus; Hepatitis C virus; India

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; INDIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; TREATMENT PLANNING;

COHORT STUDIES; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INDIA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE;

EID: 50349097304     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.02.006     Document Type: Article

References (40)

1. Stuyver L., Wyseur A., van Arnhem W., Lunel F., Laurent-Puig P., Pawlotsky J.M., et al. Hepatitis C virus genotyping by means of 50-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res 38 (1995) 137-157
2. Hepatitis C: global prevalence (update). Wkly Epidemiol Rec 2000;75:18-9.
3. Barrera J.M., Bruguera M., Ercilla M.G., Gil C., Celis R., Gil M.P., et al. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology 21 (1995) 639-644
4. Alter H.J. HCV natural history: the retrospective and prospective in perspective. J Hepatol 43 (2005) 550-552
5. Panigrahi A.K., Panda S.K., Dixit R.K., Rao K.V., Acharya S.K., Dasarathy S., et al. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver disease. J Med Virol 51 (1997) 167-174
6. Trepo C. Genotype and viral load as prognostic indicators in the treatment of hepatitis C. J Viral Hepat 7 (2000) 250-257
7. Lehmann M., Meyer M.F., Monazahian M., Tillmann H.L., Manns M.P., and Wedemeyer H. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection. J Med Virol 73 (2004) 387-391
8. Malhotra V., Sakhuja P., Gondal R., Sarin S.K., Siddhu M., and Dutt N. Histological comparison of chronic hepatitis B and C in an Indian population. Trop Gastroenterol 21 (2000) 20-21
9. Hissar S.S., Goyal A., Kumar M., Pandey C., Suneetha P.V., Sood A., et al. Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol 78 (2006) 452-458
10. Kobayashi M., Tanaka I., Sodeyama T., Urushihara A., Matsumoto A., and Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C virus. Hepatology 23 (1996) 695-699
11. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales Jr. F.L., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347 (2002) 975-982
12. Amrapurkar A., Dhorda M., Kirpalani A., Amarapurkar A., and Kankonkar X.X. Prevalence of hepatitis C genotypes in Indian patients and their clinical significance. J Assoc Physicians India 49 (2001) 983-985
13. Das B.R., Kundu B., Khandapkar R., and Sahni S. Geographic distribution of hepatitis C virus genotypes in India. Ind J Path Microbiol 45 (2002) 323-328
14. Chowdhury A., Santra A., Chaudhuri S., Dhali G.K., Chaudhuri S., and Maity S.G. Hepatitis C virus infection in the general population: a community-based study in West Bengal. India. Hepatology 37 (2003) 802-809
15. Lole K.S., Jha J.A., Shrotri S.P., Tandon B.N., Prasad V.G.M., and Arankalle V.A. Comparison of hepatitis C virus genotyping by 50 non-coding region- and core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol 41 (2003) 5240-5244
16. Chaudhuri S., Das S., Chowdhury A., Santra A., Bhattacharya S.K., and Naik T.N. Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata, India. J Clin Virol 32 (2005) 38-46
17. Sompal S., Malhotra V., and Sarin S.K. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India. Ind J Med Res 119 (2004) 145-148
18. Raghuraman S., Shaji R.V., Sridharan G., Radhakrishnan S., Chandy G., and Ramakrishna B.S. Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in South India. J Clin Virol 26 (2003) 61-69
19. Raghuraman S., Abraham P., Sridharan G., Daniel H.D., Ramakrishna B.S., and Shaji R.V. HCV genotype 4-an emerging threat as a cause of chronic liver disease in Indian (South) patients. J Virol 31 (2004) 253-258
20. Valliammai T., Thyagarajan S.P., Zuckerman A.J., and Harrison T.J. Diversity of genotypes of hepatitis C virus in southern India. J Gen Virol 76 (1995) 711-716
21. Chandra M., Khaja M.N., Farees N., Poduri C.D., Hussain M.M., Aejaz Habib M., et al. Prevalence, risk factors and genotype distribution of HCV and HBV infection in the tribal population: a community based study in South India. Trop Gastroenterol 24 (2003) 193-195
22. Goodman Z.D., and Ishak K.G. Histopathology of hepatitis C virus infection. Semin Liver Dis 15 (1995) 70-81
23. Cheung L.C., Shih J.W., Alter H.J., Lee L.M., and Gu J.R. Application of PCR for HBV subtyping. In: Hollinger F.B., Lemon S.M., and Margolis H.S. (Eds). Viral hepatitis and liver disease (1991), Williams and Wilkins, Baltimore 229-231
24. Panigrahi A.K., Roca J., Acharya S.K., Jameel S., and Panda S.K. Genotype determination of hepatitis C virus from northern India: identification of a new subtype. J Med Virol 48 (1996) 191-198
25. Le Guillou-Guillemette H., Vallet S., Gaudy-Graffin C., Payan C., Pivert A., Goudeau A., et al. Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy. World J Gastroenterol 13 (2007) 2416-2426
26. Gracia-Samaniego J., Soriano V., Castill J., Braco R., Moreno A., and Carbo J. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. Am J Gastroenterol 92 (1997) 1130-1134
27. Pozzato G., Moretti M., Franzin F., Crovatto M., Modolo M.L., and Gennari D. Severity of liver disease with different viral clones. Lancet 338 (1991) 509
28. Svirtlih N., Delic D., Simonovic J., Jevtovic D., Dokic L., Gvozdenovic E., et al. Hepatitis C virus genotypes in Serbia and Montenegro: the prevalence and clinical significance. World J Gastroenterol 13 (2007) 355-360
29. Zein N.N., Rakela J., Krawitt E.L., Reddy K.R., Tominaga T., and Persing D.H. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 125 (1996) 634-639
30. Elgouzzi M.H., Bouchardeau F., Pillonel J., Boiret E., Tirtaine C., Barlet V., et al. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors. Vox Sang 79 (2000) 138-144
31. Savvas S.P., Koskinas J., Sinani C., Hadziyannis A., Spanou F., and Hadziyannis S.J. Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat 12 (2005) 551-557
32. Dal Molin G., Ansaldi F., Biagi C., D'Agaro P., Comar M., Croce L., et al. Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. J Med Virol 68 (2002) 352-356
33. Kalinina O., Norder H., Vetrov T., Zhdanov K., Barzunova M., Plotnikova V., et al. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol 65 (2001) 517-524
34. Vince A., Palmovic D., Kutela N., Sonicky Z., Jeren T., and Radovani M. HCV genotypes in patients with chronic hepatitis C in Croatia. Infection 26 (1998) 173-177
35. Serra M.A., Rodriguez F., del Olmo J.A., Escudero A., and Rodrigo J.M. Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage. J Viral Hepat 10 (2003) 183-188
36. Cathomas G., McGandy C.E., Terracciano L.M., Gudat F., and Bianchi L. Detection and typing of hepatitis C RNA in liver biopsies and its relation to histopathology. Virchows Arch 429 (1996) 353-358
37. Pozzato G., Kaneko S., Moretti M., Croce L.S., Franzin F., Unoura M., et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 43 (1994) 291-296
38. Westin J., Nordlinder H., Lagging M., Norkrans G., and Wejstal R. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol 37 (2002) 837-842
39. Poynard T., Ratziu V., McHutchison J., Manns M., Goodman Z., and Zeuzem S. Effect of treatment with peg-interferon or interferon alpha-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 38 (2003) 75-85
40. De Torres M., and Poynard T. Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann Hepatol 2 (2003) 5-11